Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic (MindCOVID)
Clara Health

Risk Factors for Anxiety and Depression Among Pregnant Women (MindCOVID)

Sponsored by Żelazna Medical Centre

The article presents a protocol of a cross-sectional study of mental health of pregnant women in relation to the COVID 19 pandemic. The primary aim is to compare differences in anxiety and depression scores of pregnant women between countries affected by the COVID-19 pandemic. The secondary aim is to assess demographic, economic, and social aspects affecting maternal anxiety and depression scores among pregnant women worldwide in the time of the COVID-19 pandemic.

Finally, investigators will be able to compare differences in perception of the different aspects of the COVID-19 pandemic (social distancing, restrictions related to delivery) between countries and according to the epidemic status (number of infected patients, number of reported deaths). The comparisons will also be done according to COVID-19 status of the participants.


Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.

How is this study designed?

Study type: Observational Estimated Enrollment: 8500 participants Actual Study Start Date: May 1, 2020 Estimated Study Completion Date: October 31, 2020

Who is this study for?

Inclusion Criteria*:

  • declaration of being pregnant
  • being able to complete the survey in the available languages

* Additional criteria apply. Please speak with the study team for further information.

What should I expect?

This is an anonymous internet survey of pregnant women living in countries affected by COVID19.

The survey consists of three parts: 1. Questions related to general demography, pregnancy, mental health history, socio-economic factors, as well as perception of fear, burden and restrictions related to the pandemic COVID-19 and 2. General anxiety disorder-7 (GAD-7 questionnaire for anxiety Assessment 3. Patient Health Questionnaire-9 (PHQ-9) to depression evaluations.

Participate in the MindCOVID study

Thank you for your interest in advancing COVID-19 research.

Please fill out this contact form to participate in the study. The following information that you enter will only be authorized to be shared with the research team conducting this specific study.

If you have any difficulties or questions, please contact our support specialists at [email protected]

Have a question?

For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you’ll be connected to the study team.